Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12.94 USD | +5.20% | +1.97% | -9.57% |
May. 14 | Transcript : OptimizeRx Corporation, Q1 2024 Earnings Call, May 14, 2024 | |
May. 14 | OptimizeRx Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Evolution of the average Target Price on OptimizeRx Corporation
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering OptimizeRx Corporation
JMP Securities | |
RBC Capital Markets | |
Barclays | |
Roth MKM | |
Lake Street | |
Stifel Nicolaus | |
B. Riley | |
Piper Sandler | |
SVB Securities LLC | |
Roth Capital Partners |
EPS Revisions
- Stock Market
- Equities
- OPRX Stock
- Consensus OptimizeRx Corporation